• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Engine Biosciences Lands $10M for AI-Driven Drug Discovery Platform

by Jasmine Pennic 02/01/2018 Leave a Comment

Engine Biosciences Lands $10M for AI-Driven Drug Discovery Platform

Engine Biosciences(“Engine”), a San Francisco, CA-based biotech company pioneering its artificial intelligence and genomics network biomedicine platform for drug discovery has raised $10 million. The seed round was co-led by by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from global biopharmaceutical leader WuXi AppTec, EDBI, Pavilion Capital, Baidu Ventures, WI Harper, and Nest.Bio Ventures.

The company plans to utilize the funding to support its proprietary platform, Engine as it builds its drug discovery platform, expands its scientific and executive team in both Singapore and San Francisco, and pursues preclinical studies internally and with partners, which currently include leading research institutions and a prominent US Fortune 500 company. Engine’s data-driven drug discovery platform combines massively parallel biological experimentation with artificial intelligence (“AI”) to discover and develop better therapies for important human diseases.

Compared with conventional drug discovery approaches, which are too slow and costly to test and map the huge number of genetic interactions that underlie diseases, Engine’s platform drives orders-of-magnitude gains in speed and scale. By understanding and testing these genetic interactions in parallel and using machine learning and deep learning algorithms to analyze and learn from the resulting datasets, Engine can decipher biological networks that until this point have vexed drug developers and researchers and enable more rational drug discovery for both single and combination therapies.

To date, Engine’s technology is being applied across four areas: drug repositioning, which applies known drugs to novel indications; new target discovery, which identifies biological factors that underlie disease; precision medicine enablement to support unique treatments based on a patient’s particular genetic makeup; and pathway analysis. Engine has achieved proof of concept across various disease indications and cell types and has active programs in cancer, neurodegeneration, autoimmune, and skin.

“The biopharmaceutical industry needs better approaches for R&D to deliver therapies to patients in need faster. Legacy approaches mean that in many cases, we still have a weak understanding of what drives disease and correspondingly, how to treat or prevent it,” said Engine Biosciences Co-Founder and CEO Jeffrey Lu. “Engine’s data-driven platform allows researchers to uncover the critical gene interactions underlying diseases and also test therapies that specifically target these interactions in a faster, cheaper and more precise fashion than currently possible.”

RELATED:   Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease

Tagged With: Drug Discovery, Engine Biosciences, genomics, Precision Medicine

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Medidata, Syapse Partner to Democratize Access to Oncology Clinical Trials
Navicure, ZirMed Rebrands As Waystar for End-to-End Revenue Cycle Technology »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • CVS Health Launches Senior Medical Alert System, Symphony

    CVS Health Launches Senior Medical Alert System, Symphony

    ... more
  • Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health

    Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

    ... more
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup

    MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process

    ... more
  • Heritage Group

    Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021 Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |